Submit manuscript

Ef(cid:976)icacy and Safety of Antipsychotic Medications in the Treatment of Delirium

1 Department of Psychiatry, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand

Affiliation : Veevarin Charoenporn MD1


Objective : To examine the therapeutic effects and adverse events in patients with delirium after treatment by antipsychotics, which are haloperidol, risperidone, and quetiapine. Materials and Methods: Fifty-six delirious inpatients treated by haloperidol, risperidone, and quetiapine participated in this study. The type and dosage of medication depended on the judgment of psychiatrists who took care of each patient. Investigators observed the clinical progression without being involved in any treatment methods. Severity of delirium was evaluated using the Memorial Delirium Assessment Scale [MDAS]. The extrapyramidal side effect [EPS] was assessed via the Modi(cid:976)ied Simpson-Angus Scale [MSAS]. All measures were applied at the baseline (prior to the treatment) and repeated daily throughout the 7-day study. The mixed model regression analysis was used.
Results : Eleven (19.6%), 14 (25%), and 31 (55.4%) participants received haloperidol, risperidone, and quetiapine, respectively. At baseline, MDAS score (mean) of haloperidol, risperidone, and quetiapine groups were 14.5, 19.3, and 18.0, which were not statistical different. At study end, the MDAS score improved the most in risperidone group (-8.3), followed by haloperidol (-7.3), and quetiapine group (-5.9). The mixed model analysis indicated no signi(cid:976)icant differences in the improving scores between treatment groups. About 30% of patients had experienced adverse events. Most common side effects were sedation (14.3%) and EPS (10.7%). There were no statistical signi(cid:976)icant differences in side effect pro(cid:976)iles between groups.
Conclusion : Haloperidol, risperidone, and quetiapine are similarly effective in the management of delirium. No different side-effect pro(cid:976)ile was found.

Keywords : Ef(cid:976)icacy, Safety, Delirium, Antipsychotics, Haloperidol, Risperidone, Quetiapine, Extrapyramidal side effect [EPS]


All Articles Download


INFORMATION

Contact info

JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com

JMed Assoc Thai
MEDICAL ASSOCIATION OF THAILAND
ISSN: 0125-2208 (Print),
ISSN: 2408-1981 (Online)
The content of this site is intended for health professionals.

Submissions

» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement

Other

» Journal Sponsorship » Site Map » About this Publishing System

© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.